Ergoteles LLC Scopus Bio Pharma Inc. Transaction History

Ergoteles LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$4.0 - $6.99 $93,800 - $163,915	-23,450 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.17 - $10.25 $121,236 - $240,362	23,450 New	23,450 $167,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.